UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051392
Receipt number R000058627
Scientific Title Exploration of prevention and treatment of vascular cognitive impairment in patients with asymptomatic carotid artery stenosis/occlusion
Date of disclosure of the study information 2023/06/20
Last modified on 2023/06/20 14:18:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploration of prevention and treatment of vascular cognitive impairment in patients with asymptomatic carotid artery stenosis/occlusion

Acronym

Development of dementia prevention and treatment for patients with asymptomatic carotid artery stenosis/occlusion

Scientific Title

Exploration of prevention and treatment of vascular cognitive impairment in patients with asymptomatic carotid artery stenosis/occlusion

Scientific Title:Acronym

Exploration of prevention and treatment of vascular cognitive impairment in patients with asymptomatic carotid artery stenosis/occlusion

Region

Japan


Condition

Condition

Asymptomatic carotid artery stenosis/occlusion

Classification by specialty

Cardiology Neurology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

Asymptomatic carotid artery stenosis/occlusion is not only a major causative disease of cerebral infarction, but also considered to be a causaive disease of vascular cognitive impairment even without cerebral infarction. However, no preventive or therapeutic measures for vascular cognitive impairment caused by asymptomatic carotid artery stenosis/obstruction have been established. Resveratrol, which is commercially available as a dietary supplement, is expected to activate endothelial nitric oxide synthase through activation of SIRT1, a longevity gene, and we will examine whether resveratrol is associated with maintenance of cerebral blood flow plus maintenance/improvement of cognitive function.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Preservation/improvement of cognitive function in patients with asymptomatic carotid artery stenosis/occlusion

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The inclusion criteria of patients who visited NCVC between July 2020 and March 2025 were as follows:
(i) Patients with asymptomatic CASO who showed a peak systolic velocity of>130 cm/s at a stenotic lesion or occlusion identified by carotid Doppler ultrasonography.(ii) Patients who underwent neuropsychological examinations including Montreal Cognitive Assessment (MoCA) and Alzheimer's Disease Assessment Scale-Cognitive Subscale 13 (ADAS-Cog). (iii) Patients who underwent also 15O-gas PET.

Key exclusion criteria

Patients deemed by the investigator to be ineligible for participation in this study.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Yorito
Middle name
Last name Hattori

Organization

National Cerebral and Cardiovascular Center

Division name

Department of Neurology

Zip code

564-8565

Address

6-1, Kishibe-shimmachi, Suita, Osaka

TEL

06-6170-1070

Email

yoh2019@ncvc.go.jp


Public contact

Name of contact person

1st name Yorito
Middle name
Last name Hattori

Organization

National Cerebral and Cardiovascular Center

Division name

Department of Neurology

Zip code

564-8565

Address

6-1, Kishibe-shimmachi, Suita, Osaka

TEL

06-6170-1070

Homepage URL


Email

yoh2019@ncvc.go.jp


Sponsor or person

Institute

National Cerebral and Cardiovascular Center

Institute

Department

Personal name



Funding Source

Organization

Terumo Life Science Foundation, Research Foundation for Dementia of Osaka, Japan Geriatrics Society, Daiwa Securities Health Foundation, Health Science Center

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Committee, National Cerebral and Cardiovascular Center

Address

6-1, Kishibe-shimmachi, Suita, Osaka

Tel

06-6170-1070

Email

rec-office-ac@ncvc.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 06 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 02 Month 22 Day

Date of IRB

2021 Year 02 Month 22 Day

Anticipated trial start date

2021 Year 02 Month 22 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

N/A


Management information

Registered date

2023 Year 06 Month 20 Day

Last modified on

2023 Year 06 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058627


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name